Cellular hypoxia and adipose tissue dysfunction in obesity

Proceedings of the Nutrition Society

Volumn 68, Issue 4, 2009, Pages 370-377

  Wood, I Stuart ^a   De Heredia, Fátima Pérez ^a   Wang, Bohan ^a   Trayhurn, Paul ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Adipose tissue dysfunction; Hypoxia; Hypoxic inducible factor 1; Inflammatory adipokines

Indexed keywords

GLUCOSE TRANSPORTER 1; HYPOXIA INDUCIBLE FACTOR 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; LEPTIN; MACROPHAGE MIGRATION INHIBITION FACTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; ADIPOCYTOKINE; ADIPONECTIN; GLUCOSE; OXYGEN;

ADIPOSE TISSUE; CELL DIFFERENTIATION; CELL HYPOXIA; CONFERENCE PAPER; CYTOKINE PRODUCTION; HUMAN; IMMUNOREGULATION; INFLAMMATION; INSULIN RESISTANCE; NONHUMAN; OBESITY; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; TRANSCRIPTION REGULATION; ADIPOCYTE; ANIMAL; BIOSYNTHESIS; CYTOLOGY; MACROPHAGE; METABOLISM; MOUSE; PHYSIOLOGY; REVIEW; TRANSPORT AT THE CELLULAR LEVEL; UPREGULATION; WHITE ADIPOSE TISSUE;

ANIMALIA; MUS;

ADIPOCYTES; ADIPOKINES; ADIPONECTIN; ADIPOSE TISSUE, WHITE; ANIMALS; BIOLOGICAL TRANSPORT; CELL DIFFERENTIATION; CELL HYPOXIA; GLUCOSE; GLUCOSE TRANSPORTER TYPE 1; HUMANS; INFLAMMATION; MACROPHAGES; MICE; OBESITY; OXYGEN; UP-REGULATION;

EID: 77949329629     PISSN: 00296651     EISSN: 14752719     Source Type: Journal    
DOI: 10.1017/S0029665109990206     Document Type: Conference Paper

References (84)

1. Zhang Y, Proenca R, Maffei M et al. (1994) Positional cloning of the mouse obese gene and its human homologue. Nature 372, 425-432.
2. Trayhurn P & Beattie JH (2001) Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ. Proc Nutr Soc 60, 329-339.
3. Trayhurn P & Wood IS (2004) Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 92, 347-355.
4. Fantuzzi G (2005) Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 115, 911-919.
5. Rosen ED & Spiegelman BM (2006) Adipocytes as regulators of energy balance and glucose homeostasis. Nature 444, 847-853.
6. McPherson K, Marsh T & Brown M (2007) Foresight. Tackling Obesities: Future Choices - Modelling Future Trends in Obesity and the Impact on Health, 2nd ed. London: The Stationery Office.
7. Phillips LK & Prins JB (2008) The link between abdominal obesity and the metabolic syndrome. Curr Hypertens Rep 10, 156-164.
8. Cancer Research UK (2009) Bodyweight and risk of cancer in the UK. http://info.cancerresearchuk.org/cancerstats/causes/ lifestyle/bodyweight/
9. Engstrom G, Hedblad B, Stavenow L et al. (2003) Inflammation- sensitive plasma proteins are associated with future weight gain. Diabetes 52, 2097-2101.
10. Festa A, D'Agostino R Jr, Williams K et al. (2001) The relation of body fat mass and distribution to markers of chronic inflammation. Int J Obes Relat Metab Disord 25, 1407-1415.
11. Yudkin JS (2003) Adipose tissue, insulin action and vascular disease: inflammatory signals. Int J Obes 27, Suppl. 3, S25-S28.
12. Yudkin JS, Stehouwer CD, Emeis JJ et al. (1999) C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 19, 972-978.
13. Hotamisligil GS, Shargill NS & Spiegelman BM (1993) Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259, 87-91.
14. Fain JN (2006) Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells. Vitam Horm 74, 443-477.
15. Arita Y, Kihara S, Ouchi N et al. (1999) Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257, 79-83.
16. Ouchi N, Kihara S, Arita Y et al. (1999) Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 100, 2473-2476.
17. Hotta K, Funahashi T, Arita Y et al. (2000) Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 20, 1595-1599.
18. Weisberg SP, McCann D, Desai M et al. (2003) Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112, 1796-1808.
19. Xu H, Barnes GT, Yang Q et al. (2003) Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112, 1821-1830.
20. Bouloumie A, Curat CA, Sengenes C et al. (2005) Role of macrophage tissue infiltration in metabolic diseases. Curr Opin Clin Nutr Metab Care 8, 347-354.
21. Curat CA, Miranville A, Sengenes C et al. (2004) From blood monocytes to adipose tissue-resident macrophages: induction of diapedesis by human mature adipocytes. Diabetes 53, 1285-1292.
22. Fleischmann E, Kurz A, Niedermayr M et al. (2005) Tissue oxygenation in obese and non-obese patients during laparoscopy. Obes Surg 15, 813-819.
23. Rupnick MA, Panigrahy D, Zhang CY et al. (2002) Adipose tissue mass can be regulated through the vasculature. Proc Natl Acad Sci USA 99, 10730-10735.
24. Lolmede K, Durand de Saint Front V, Galitzky J et al. (2003) Effects of hypoxia on the expression of proangiogenic factors in differentiated 3T3-F442A adipocytes. Int J Obes Relat Metab Disord 27, 1187-1195.
25. Ambrosini G, Nath AK, Sierra-Honigmann MR et al. (2002) Transcriptional activation of the human leptin gene in response to hypoxia. Involvement of hypoxia-inducible factor 1. J Biol Chem 277, 34601-34609.
26. Grosfeld A, Andre J, Hauguel-De Mouzon S et al. (2002) Hypoxia-inducible factor 1 transactivates the human leptin gene promoter. J Biol Chem 277, 42953-42957.
27. Grosfeld A, Zilberfarb V, Turban S et al. (2002) Hypoxia increases leptin expression in human PAZ6 adipose cells. Diabetologia 45, 527-530.
28. Kabon B, Nagele A, Reddy D et al. (2004) Obesity decreases perioperative tissue oxygenation. Anesthesiology 100, 274-280.
29. Karpe F, Fielding BA, Ilic V et al. (2002) Impaired postprandial adipose tissue blood flow response is related to aspects of insulin sensitivity. Diabetes 51, 2467-2473.
30. Skurk T, Alberti-Huber C, Herder C et al. (2007) Relationship between adipocyte size and adipokine expression and secretion. J Clin Endocrinol Metab 92, 1023-1033.
31. Brahimi-Horn MC & Pouyssegur J (2007) Oxygen, a source of life and stress. FEBS Lett 581, 3582-3591.
32. Semenza GL & Wang GL (1992) A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol 12, 5447-5454.
33. Wang GL & Semenza GL (1993) General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia. Proc Natl Acad Sci USA 90, 4304-4308.
34. Semenza GL (1998) Hypoxia-inducible factor 1: master regulator of O2 homeostasis. Curr Opin Genet Dev 8, 588-594.
35. Semenza GL (2003) Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3, 721-732.
36. Patel SA & Simon MC (2008) Biology of hypoxia-inducible factor-2alpha in development and disease. Cell Death Differ 15, 628-634.
37. Bardos JI & Ashcroft M (2005) Negative and positive regulation of HIF-1: a complex network. Biochim Biophys Acta 1755, 107-120.
38. Leonard MO, Howell K, Madden SF et al. (2008) Hypoxia selectively activates the CREB family of transcription factors in the in vivo lung. Am J Respir Crit Care Med 178, 977-983.
39. Taylor CT (2008) Interdependent roles for hypoxia inducible factor and nuclear factor-kappaB in hypoxic inflammation. J Physiol 586, 4055-4059.
40. Hosogai N, Fukuhara A, Oshima K et al. (2007) Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation. Diabetes 56, 901-911.
41. Ye J, Gao Z, Yin J et al. (2007) Hypoxia is a potential risk factor for chronic inflammation and adiponectin reduction in adipose tissue of ob/ob and dietary obese mice. Am J Physiol Endocrinol Metab 293, E1118-E1128.
42. Pasarica M, Sereda OR, Redman LM et al. (2009) Reduced adipose tissue oxygenation in human obesity: evidence for rarefaction, macrophage chemotaxis, and inflammation without an angiogenic response. Diabetes 58, 718-725.
43. Wang B, Wood IS & Trayhurn P (2007) Dysregulation of the expression and secretion of inflammation-related adipokines by hypoxia in human adipocytes. Pflugers Arch 455, 479-492.
44. Wood IS, Wang B, Lorente-Cebrian S et al. (2007) Hypoxia increases expression of selective facilitative glucose transporters (GLUT) and 2-deoxy-D-glucose uptake in human adipocytes. Biochem Biophys Res Commun 361, 468-473.
45. Chen B, Lam KS, Wang Y et al. (2006) Hypoxia dysregulates the production of adiponectin and plasminogen activator inhibitor-1 independent of reactive oxygen species in adipocytes. Biochem Biophys Res Commun 341, 549-556.
46. Wang B, Wood IS & Trayhurn P (2008) PCR arrays identify metallothionein-3 as a highly hypoxia-inducible gene in human adipocytes. Biochem Biophys Res Commun 368, 88-93.
47. Tanji K, Irie Y, Uchida Y et al. (2003) Expression of metallothionein-III induced by hypoxia attenuates hypoxiainduced cell death in vitro. Brain Res 976, 125-129.
48. Semenza GL (2007) Oxygen-dependent regulation of mitochondrial respiration by hypoxia-inducible factor 1. Biochem J 405, 1-9.
49. Regazzetti C, Peraldi P, Gremeaux T et al. (2009) Hypoxia decreases insulin signaling pathways in adipocytes. Diabetes 58, 95-103.
50. Yin J, Gao Z, He Q et al. (2009) Role of hypoxia in obesityinduced disorders of glucose and lipid metabolism in adipose tissue. Am J Physiol Endocrinol Metab 296, E333-E342.
51. Wood IS, Hunter L & Trayhurn P (2003) Expression of Class III facilitative glucose transporter genes (GLUT-10 and GLUT-12) in mouse and human adipose tissues. Biochem Biophys Res Commun 308, 43-49.
52. Wood IS & Trayhurn P (2003) Glucose transporters (GLUT and SGLT): expanded families of sugar transport proteins. Br J Nutr 89, 3-9.
53. Douen A, Ramlal T, Rastogi S et al. (1990) Exercise induces recruitment of the 'insulin-responsive glucose transporter'. Evidence for distinct intracellular insulin- and exerciserecruitable transporter pools in skeletal muscle. J Biol Chem 265, 13427-13430.
54. Zierath JR, Tsao TS, Stenbit AE et al. (1998) Restoration of hypoxia-stimulated glucose uptake in GLUT4-deficient muscles by muscle-specific GLUT4 transgenic complementation. J Biol Chem 273, 20910-20915.
55. Meredith D & Christian HC (2008) The SLC16 monocaboxylate transporter family. Xenobiotica 38, 1072-1106.
56. Ullah MS, Davies AJ & Halestrap AP (2006) The plasma membrane lactate transporter MCT4, but not MCT1, is upregulated by hypoxia through a HIF-1alpha-dependent mechanism. J Biol Chem 281, 9030-9037.
57. de Luca C & Olefsky JM (2008) Inflammation and insulin resistance. FEBS Lett 582, 97-105.
58. Shepherd PR & Kahn BB (1999) Glucose transporters and insulin action - implications for insulin resistance and diabetes mellitus. N Engl J Med 341, 248-257.
59. Abel ED, Peroni O, Kim JK et al. (2001) Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver. Nature 409, 729-733.
60. Pérez de Heredia F, Wood IS & Trayhurn P (2009) Acute and chronic hypoxia selectively modulates the expression of glucose transporters (GLUTs) in human adipocytes. Obes Facts 2, Suppl. 2, 39.
61. Chung S, Lapoint K, Martinez K et al. (2006) Preadipocytes mediate lipopolysaccharide-induced inflammation and insulin resistance in primary cultures of newly differentiated human adipocytes. Endocrinology 147, 5340-5351.
62. Simons PJ, van den Pangaart PS, van Roomen CP et al. (2005) Cytokine-mediated modulation of leptin and adiponectin secretion during in vitro adipogenesis: evidence that tumor necrosis factor-alpha- and interleukin-1beta-treated human preadipocytes are potent leptin producers. Cytokine 32, 94-103.
63. Yun Z, Maecker HL, Johnson RS et al. (2002) Inhibition of PPAR gamma 2 gene expression by the HIF-1-regulated gene DEC1/Stra13: a mechanism for regulation of adipogenesis by hypoxia. Dev Cell 2, 331-341.
64. Carriere A, Carmona MC, Fernandez Y et al. (2004) Mitochondrial reactive oxygen species control the transcription factor CHOP-10/GADD153 and adipocyte differentiation: a mechanism for hypoxia-dependent effect. J Biol Chem 279, 40462-40469.
65. Kim KH, Song MJ, Chung J et al. (2005) Hypoxia inhibits adipocyte differentiation in a HDAC-independent manner. Biochem Biophys Res Commun 333, 1178-1184.
66. Zhou S, Lechpammer S, Greenberger JS et al. (2005) Hypoxia inhibition of adipocytogenesis in human bone marrow stromal cells requires transforming growth factorbeta/ Smad3 signaling. J Biol Chem 280, 22688-22696.
67. Wang B, Wood IS & Trayhurn P (2008) Hypoxia induces leptin gene expression and secretion in human preadipocytes: differential effects of hypoxia on adipokine expression by preadipocytes. J Endocrinol 198, 127-134.
68. Sagawa N, Yura S, Itoh H et al. (2002) Role of leptin in pregnancy-a review. Placenta 23, Suppl. A, S80-S86.
69. Lewis JS, Lee JA, Underwood JC et al. (1999) Macrophage responses to hypoxia: relevance to disease mechanisms. J Leukoc Biol 66, 889-900.
70. Oda T, Hirota K, Nishi K et al. (2006) Activation of hypoxiainducible factor 1 during macrophage differentiation. Am J Physiol Cell Physiol 291, C104-C113.
71. Rausch ME, Weisberg S, Vardhana P et al. (2008) Obesity in C57BL/6J mice is characterized by adipose tissue hypoxia and cytotoxic T-cell infiltration. Int J Obes (Lond) 32, 451-463.
72. Skurk T, Herder C, Kraft I et al. (2005) Production and release of macrophage migration inhibitory factor from human adipocytes. Endocrinology 146, 1006-1011.
73. Trayhurn P, Wang B & Wood IS (2008) Hypoxia in adipose tissue: a basis for the dysregulation of tissue function in obesity? Br J Nutr 100, 227-235.
74. Gruen ML, Hao M, Piston DW et al. (2007) Leptin requires canonical migratory signaling pathways for induction of monocyte and macrophage chemotaxis. Am J Physiol Cell Physiol 293, C1481-C1488.
75. Trayhurn P & Wood IS (2005) Signalling role of adipose tissue: adipokines and inflammation in obesity. Biochem Soc Trans 33, 1078-1081.
76. Constant VA, Gagnon A, Landry A et al. (2006) Macrophage- conditioned medium inhibits the differentiation of 3T3-L1 and human abdominal preadipocytes. Diabetologia 49, 1402-1411.
77. Lacasa D, Taleb S, Keophiphath M et al. (2007) Macrophage-secreted factors impair human adipogenesis: involvement of proinflammatory state in preadipocytes. Endocrinology 148, 868-877.
78. Permana PA, Menge C & Reaven PD (2006) Macrophagesecreted factors induce adipocyte inflammation and insulin resistance. Biochem Biophys Res Commun 341, 507-514.
79. Permana PA, Zhang W, Wabitsch M et al. (2009) Pioglitazone reduces inflammatory responses of human adipocytes to factors secreted by monocytes/macrophages. Am J Physiol Endocrinol Metab 296, E1076-E1084.
80. Houstis N, Rosen ED & Lander ES (2006) Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 440, 944-948.
81. Gregor MF & Hotamisligil GS (2007) Adipocyte stress: the endoplasmic reticulum and metabolic disease. J Lipid Res 48, 1905-1914.
82. Ozcan U, Cao Q, Yilmaz E et al. (2004) Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 306, 457-461.
83. Williams A & Scharf SM (2007) Obstructive sleep apnea, cardiovascular disease, and inflammation - is NF-kappaB the key? Sleep Breath 11, 69-76.
84. Sheehan AL, Warren BF, Gear MW et al. (1992) Fat-wrapping in Crohn's disease: pathological basis and relevance to surgical practice. Br J Surg 79, 955-958.